As the president and CEO of Vir Biotechnology, as well as in his role as head of BIO’s Coronavirus Collaboration Initiative, George Scangos has emerged as a global leader in the fight against COVID-19. In this conversation with Stanford structural biology professor Jody Puglisi, Dr. Scangos explains the challenge of building financially viable therapies for infectious diseases, talks about the current status of COVID-related research, and explores how to build an innovative and meaningful career in biotech.

Video clips from: Making a Difference in Biotech [Entire Talk]

7 minutes

Going All-In on Infectious Diseases

Watch now

4 minutes

Preparing the Market

Watch now

3 minutes

Urgency and Purpose

Watch now

4 minutes

The Accelerating Pace of Biotech Innovation

Watch now

2 minutes

The Evolution of Biotech

Watch now

Share Post